Your browser doesn't support javascript.
loading
Efficacy and safety of combination targeted therapies in immune-mediated inflammatory disease: the COMBIO study.
Guillo, Lucas; Flachaire, Benoit; Avouac, Jérôme; Dong, Catherine; Nachury, Maria; Bouguen, Guillaume; Buisson, Anthony; Caillo, Ludovic; Fumery, Mathurin; Gilletta, Cyrielle; Hébuterne, Xavier; Lafforgue, Pierre; Laharie, David; Mahé, Emmanuel; Marotte, Hubert; Nancey, Stéphane; Ottaviani, Sébastien; Salmon, Jean-Hugues; Savoye, Guillaume; Serrero, Mélanie; Uzzan, Mathieu; Viguier, Manuelle; Richez, Christophe; Peyrin-Biroulet, Laurent; Seksik, Philipe; Pham, Thao.
Afiliação
  • Guillo L; Aix Marseille Univ, APHM, University Hospital of Marseille Nord, Department of Gastroenterology, Marseille, France. Electronic address: lucas.guillo690@gmail.com.
  • Flachaire B; Aix Marseille Univ, APHM, University Hospital of Marseille Sainte-Marguerite, Department of Rheumatology, Marseille, France.
  • Avouac J; Université de Paris, service de rhumatologie, hôpital Cochin, AP-HP.CUP, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France.
  • Dong C; Service de Gastro-Entérologie, Assistance publique-Hôpitaux de Paris (AP-HP), hôpital Bicêtre, 94270 Le Kremlin-Bicêtre, France.
  • Nachury M; Université de Lille, Inserm, CHU Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation, F-59000 Lille, France.
  • Bouguen G; CHU Rennes, Univ Rennes, INSERM, CIC1414, Institut NUMECAN (Nutrition Metabolisms and Cancer), 35000 Rennes, France.
  • Buisson A; Université Clermont Auvergne, 3iHP, CHU Clermont-Ferrand, Service d'Hépato-Gastroentérologie, Inserm U1071, M2iSH, USC-INRA 2018, Clermont-Ferrand, France.
  • Caillo L; Department of Gastroenterology, University Hospital of Nimes, Nimes, France.
  • Fumery M; Department of Gastroenterology, Amiens University Medical Center and PeriTox UMR I-O1, Jules Verne University of Picardie, Amiens, France.
  • Gilletta C; Department of Gastroenterology, Toulouse University Hospital, Toulouse, France.
  • Hébuterne X; Gastroenterology and Clinical Nutrition, CHU of Nice, University Côte d'Azur, Nice, France.
  • Lafforgue P; Aix Marseille Univ, APHM, University Hospital of Marseille Sainte-Marguerite, Department of Rheumatology, Marseille, France.
  • Laharie D; CHU de Bordeaux, Hôpital Haut-Lévêque, Service d'Hépato-gastroentérologie et oncologie digestive - Université de Bordeaux, F-33000 Bordeaux, France.
  • Mahé E; Dermatology Department, Hôpital Victor Dupouy, Argenteuil, France. Groupe de recherche sur le Psoriasis (GrPso) de la Société Française de Dermatologie.
  • Marotte H; Department of Rheumatology, Inserm U1059-LBTO, CHU Saint-Etienne, Saint-Etienne, France.
  • Nancey S; Department of Gastroenterology, Inserm U1111-CIRI, Lyon-Sud University Hospital, Hospices Civils de Lyon, Pierre Bénite, France.
  • Ottaviani S; Departement of Rheumatology, DMU Locomotion, Hôpital Bichat-Claude Bernard, APHP, Université de Paris, Paris, France.
  • Salmon JH; Department of Rheumatology and EA 3797, University of Reims Champagne-Ardenne, Reims, France.
  • Savoye G; Department of Gastroenterology, Rouen University Hospital, Rouen, France.
  • Serrero M; Aix Marseille Univ, APHM, University Hospital of Marseille Nord, Department of Gastroenterology, Marseille, France.
  • Uzzan M; Department of Gastroenterology, IBD unit, Beaujon Hospital, APHP, Clichy, France.
  • Viguier M; Department of Dermatology-Venereology, Hôpital Robert Debré, Université Reims Champagne-Ardenne, Reims, France.
  • Richez C; Rheumatology Department, CHU de Bordeaux, and ImmunoConcEpt, CNRS, UMR 5164, University of Bordeaux, Bordeaux, France.
  • Peyrin-Biroulet L; Department of Gastroenterology and INSERM NGERE U1256, University Hospital of Nancy, University of Lorraine, Vandoeuvre-lès-Nancy, France.
  • Seksik P; Department of Gastroenterology, Centre de recherche Saint-Antoine, Sorbonne Université, INSERM, APHP, Hôpital Saint-Antoine, Paris, France.
  • Pham T; Aix Marseille Univ, APHM, University Hospital of Marseille Sainte-Marguerite, Department of Rheumatology, Marseille, France.
Dig Liver Dis ; 55(1): 61-68, 2023 01.
Article em En | MEDLINE | ID: mdl-35985961

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Crohn Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Crohn Idioma: En Ano de publicação: 2023 Tipo de documento: Article